PM360

JULY 21, 2022

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

Pharma Marketing Network

OCTOBER 13, 2020

Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for various parts of the system to get to what becomes the steady state – a new way of operating, the new normal. How does the situation impact pharma?

Physicians 105

Physicians Pharma Pharma reps Pharma Rep 105

Pharmaceutical Representative Training

DECEMBER 28, 2021

Before 2020, the landscape of drug marketing involved following drug approvals by the Food and Drug Administration ( FDA ), finding which patient population would benefit from therapy, and visiting specialized doctors in-person to advertise its advantages compared to current guidelines. The technology identifies.

Marketing 52

Marketing Food and Drug Administration Pharma Doctors 52

Quantified

APRIL 18, 2022

A global head of sales at a pharma company recently told me that “only 15% of our sales calls end in a positive outcome.”. In the context of a new medical innovation where there is a high unmet patient need, this means patients are not getting rapid access to medicines that can positively impact or even extend their lives.

Sales 52

Sales Pharma Pharma sales reps Medicine 52